C
Bio-Techne Corporation TECH
$55.89 -$1.96-3.39% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -48.71% -48.26% -56.34% -35.14% -29.45%
Total Depreciation and Amortization -6.65% -4.02% 1.22% -3.06% -2.95%
Total Amortization of Deferred Charges -5.58% -5.58% -5.58% 5.19% 5.19%
Total Other Non-Cash Items 127.14% 114.68% 216.74% 954.27% 752.21%
Change in Net Operating Assets -395.04% -16,199.25% 214.18% -88.69% 87.47%
Cash from Operations -18.18% -17.21% -3.82% -13.70% 10.23%
Capital Expenditure 47.84% 53.48% 50.69% 20.87% 1.22%
Sale of Property, Plant, and Equipment 194.86% -- -- -- --
Cash Acquisitions -- -- -- 100.00% 100.00%
Divestitures -- -- -- -- --
Other Investing Activities 316.74% 181.65% -122.41% -107.90% 98.35%
Cash from Investing 73.48% 81.74% 82.67% 77.69% 87.73%
Total Debt Issued -- 60.00% -53.78% -83.11% -100.00%
Total Debt Repaid 2.04% 49.27% 69.92% 52.91% 0.68%
Issuance of Common Stock -31.39% -30.02% -15.09% 47.47% 121.21%
Repurchase of Common Stock -156.87% -230.59% -176.95% -79.58% 26.86%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 1.48% 0.61% 0.06% -0.48% -0.47%
Other Financing Activities -- -- -- -- --
Cash from Financing -21.05% -39.45% -107.44% -158.36% -278.12%
Foreign Exchange rate Adjustments 344.39% -51.18% 611.23% 144.03% 163.43%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -109.85% -209.52% 136.12% -94.02% 237.24%